HK1213894A1 - 埃克替尼和鹽酸埃克替尼的製備方法及其中間體 - Google Patents
埃克替尼和鹽酸埃克替尼的製備方法及其中間體Info
- Publication number
- HK1213894A1 HK1213894A1 HK16101929.6A HK16101929A HK1213894A1 HK 1213894 A1 HK1213894 A1 HK 1213894A1 HK 16101929 A HK16101929 A HK 16101929A HK 1213894 A1 HK1213894 A1 HK 1213894A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- icotinib
- intermediates
- methods
- preparing
- hydrochloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D325/00—Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups C07D303/00 - C07D323/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011081586 | 2011-10-31 | ||
| CN201280055394.XA CN104024262B (zh) | 2011-10-31 | 2012-12-28 | 埃克替尼和盐酸埃克替尼的制备方法及其中间体 |
| PCT/CN2012/087802 WO2013064128A1 (zh) | 2011-10-31 | 2012-12-28 | 埃克替尼和盐酸埃克替尼的制备方法及其中间体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1213894A1 true HK1213894A1 (zh) | 2016-07-15 |
Family
ID=48191387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16101929.6A HK1213894A1 (zh) | 2011-10-31 | 2016-02-22 | 埃克替尼和鹽酸埃克替尼的製備方法及其中間體 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9085588B2 (zh) |
| EP (1) | EP2796461B1 (zh) |
| CN (2) | CN104024262B (zh) |
| AU (1) | AU2012331547C1 (zh) |
| BR (1) | BR112014010479A2 (zh) |
| CA (1) | CA2854083C (zh) |
| ES (1) | ES2641953T3 (zh) |
| HK (1) | HK1213894A1 (zh) |
| IN (1) | IN2014MN00842A (zh) |
| SG (1) | SG11201401953WA (zh) |
| WO (1) | WO2013064128A1 (zh) |
| ZA (1) | ZA201403858B (zh) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2854083C (en) * | 2011-10-31 | 2016-12-13 | Betta Pharmaceuticals Co., Ltd. | Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereof |
| CN104487443B (zh) * | 2013-06-09 | 2016-03-23 | 贝达药业股份有限公司 | 埃克替尼马来酸盐的晶型及其用途 |
| JP6523259B2 (ja) | 2013-06-09 | 2019-05-29 | ベータ ファーマシューティカルズ カンパニー リミテッド | イコチニブリン酸塩の新規な多形及びその使用 |
| RU2710013C2 (ru) | 2013-06-09 | 2019-12-24 | Бетта Фармасьютикалз Ко., Лтд | Полиморфные формы икотиниба и их применения |
| CN104470526B (zh) * | 2013-06-09 | 2016-07-13 | 贝达药业股份有限公司 | 埃克替尼磷酸盐的晶型及其用途 |
| CN104470929B (zh) * | 2013-06-09 | 2018-11-30 | 贝达药业股份有限公司 | 埃克替尼的晶型及其应用 |
| CA2914854C (en) | 2013-06-09 | 2017-08-22 | Betta Pharmaceuticals Co., Ltd | Polymorph forms of icotinib maleate and uses thereof |
| CN103724376A (zh) * | 2013-12-31 | 2014-04-16 | 同济大学 | 新型潜在抗肿瘤药物铂配合物及其制备方法 |
| WO2021094379A1 (en) | 2019-11-12 | 2021-05-20 | Astrazeneca Ab | Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer |
| CA3166980A1 (en) | 2020-01-20 | 2021-07-29 | Astrazeneca Ab | Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer |
| CN111763214B (zh) * | 2020-08-10 | 2022-03-15 | 苏州富士莱医药股份有限公司 | 一种埃克替尼的制备方法 |
| CN114276324A (zh) * | 2021-12-31 | 2022-04-05 | 浙江拓普药业股份有限公司 | 一种埃克替尼中间体的制备方法及其应用 |
| WO2023187037A1 (en) | 2022-03-31 | 2023-10-05 | Astrazeneca Ab | Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors in combination with an akt inhibitor for the treatment of cancer |
| WO2024002938A1 (en) | 2022-06-27 | 2024-01-04 | Astrazeneca Ab | Combinations involving epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7078409B2 (en) | 2002-03-28 | 2006-07-18 | Beta Pharma, Inc. | Fused quinazoline derivatives useful as tyrosine kinase inhibitors |
| CN1305468C (zh) | 2003-05-29 | 2007-03-21 | 中国人民解放军第三○二医院 | 波棱素化合物及其制法和其药物组合物与用途 |
| WO2007138613A2 (en) * | 2006-05-25 | 2007-12-06 | Vittal Mallya Scientific Research Foundation | A process for synthesis of [6,7-bis-(2-methoxyethoxy)-quinazolin-4-yl]-(3-ethynylphenyl)amine hydrochloride |
| CN104592242B (zh) * | 2008-07-08 | 2017-01-25 | 贝达药业股份有限公司 | 埃克替尼盐酸盐晶型、药物组合物和用途 |
| ES2598530T3 (es) * | 2010-07-14 | 2017-01-27 | Betta Pharmaceuticals Co., Ltd. | Nuevos derivados heterocíclicos condensados útiles como inhibidores de la tirosina quinasa c-Met |
| CA2854083C (en) * | 2011-10-31 | 2016-12-13 | Betta Pharmaceuticals Co., Ltd. | Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereof |
-
2012
- 2012-12-28 CA CA2854083A patent/CA2854083C/en active Active
- 2012-12-28 WO PCT/CN2012/087802 patent/WO2013064128A1/zh active Application Filing
- 2012-12-28 CN CN201280055394.XA patent/CN104024262B/zh active Active
- 2012-12-28 EP EP12846055.7A patent/EP2796461B1/en active Active
- 2012-12-28 CN CN201510388082.6A patent/CN105237510A/zh active Pending
- 2012-12-28 AU AU2012331547A patent/AU2012331547C1/en active Active
- 2012-12-28 ES ES12846055.7T patent/ES2641953T3/es active Active
- 2012-12-28 BR BR112014010479A patent/BR112014010479A2/pt not_active Application Discontinuation
- 2012-12-28 IN IN842MUN2014 patent/IN2014MN00842A/en unknown
- 2012-12-28 US US14/355,142 patent/US9085588B2/en active Active
- 2012-12-28 SG SG11201401953WA patent/SG11201401953WA/en unknown
-
2014
- 2014-05-27 ZA ZA2014/03858A patent/ZA201403858B/en unknown
-
2016
- 2016-02-22 HK HK16101929.6A patent/HK1213894A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2796461A4 (en) | 2015-05-27 |
| RU2014121337A (ru) | 2015-12-10 |
| BR112014010479A2 (pt) | 2017-04-25 |
| US9085588B2 (en) | 2015-07-21 |
| CA2854083C (en) | 2016-12-13 |
| IN2014MN00842A (zh) | 2015-07-03 |
| CA2854083A1 (en) | 2013-05-10 |
| WO2013064128A1 (zh) | 2013-05-10 |
| CN104024262A (zh) | 2014-09-03 |
| ES2641953T3 (es) | 2017-11-14 |
| AU2012331547B2 (en) | 2015-07-16 |
| SG11201401953WA (en) | 2014-09-26 |
| US20140343283A1 (en) | 2014-11-20 |
| AU2012331547C1 (en) | 2016-04-21 |
| ZA201403858B (en) | 2015-12-23 |
| EP2796461B1 (en) | 2017-09-06 |
| CN104024262B (zh) | 2017-03-22 |
| AU2012331547A1 (en) | 2014-05-29 |
| EP2796461A1 (en) | 2014-10-29 |
| CN105237510A (zh) | 2016-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1213894A1 (zh) | 埃克替尼和鹽酸埃克替尼的製備方法及其中間體 | |
| HRP20170961T1 (hr) | Postupak dobivanja karbamoilpiridonskih derivata i međuprodukata | |
| EP2744331A4 (en) | METHOD AND INTERMEDIATE PRODUCTS FOR THE MANUFACTURE OF MACROLACTAMEN | |
| PL2489670T3 (pl) | Sposób wytwarzania związków chelatów aminokwasowych, związki chelatów aminokwasowych i zastosowanie związków chelatów aminokwasowych | |
| EP2731429A4 (en) | COMPOUNDS, METHODS OF PREPARATION AND METHODS OF USE | |
| EP2718331A4 (en) | N, N, N-TRIALKYL POLYMERS, METHODS FOR THEIR PREPARATION, AND USES THEREOF | |
| EP2718304A4 (en) | PROCESS FOR THE PREPARATION OF AN ETHYLENE COPOLYMER-OIL-DIET | |
| EP2725010A4 (en) | AMID CONNECTION, MANUFACTURING METHOD AND USE | |
| EP2691396A4 (en) | ENOPEPTINES, USES THEREOF, AND METHODS OF SYNTHESIZING THE SAME | |
| EP2759529A4 (en) | PROCESS FOR PREPARING 1-PALMITOYL-3-ACETYLGLYCEROL AND PROCESS FOR PREPARING 1-PALMITOYL-2-LINOLEOYL-3-ACETYLGLYCEROL THEREWITH | |
| ZA201308268B (en) | Herbicidal composition comprising pinoxaden and fluroxypyrester, and methods of use thereof | |
| SI2757878T1 (sl) | Postopek za pripravo in nadgradnjo podkev | |
| EP2688901A4 (en) | INHIBITORS OF 17SS-HSD1, 17SS-HSD3 AND 17SS-HSD10 | |
| HK1194733A1 (zh) | 製備 -酰基- -苯基磺酰基脯氨酰胺衍生物的方法及中間體 | |
| ZA201306212B (en) | An improved process for the preparation of voriconazole and intermediates thereof | |
| EP2752419A4 (en) | SPIROBENZYLAMINE-PHOSPHINE, ITS PREPARATION METHOD AND USE | |
| EP2746286A4 (en) | HOMOHARRINGTONIN AMINO DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF | |
| EP2711354A4 (en) | PROCESS FOR THE PREPARATION OF RIVASTIGMIN, INTERMEDIATE PRODUCTS AND MANUFACTURING PROCESS FOR THESE INTERMEDIATE PRODUCTS | |
| IL229426A0 (en) | processes and intermediates | |
| PL395425A1 (pl) | Sposób wytwarzania chlorowodorku 2-amino-N-tert-butylo-2- cyjanoacetamidu | |
| EP2765133A4 (en) | ACYLATED HOMO-HARRINGTONINE DERIVATIVE, METHOD FOR ITS PREPARATION AND ITS USE |